Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

NCT00111761 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Irinotecan
BIOLOGICAL: Panitumumab
DRUG: 5-Fluorouracil
DRUG: Leucovorin

Sponsor

Amgen